Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
At Neuragenex, we can help provide long-term relief from the pain and inflammation that are associated with tight pelvic floor muscles by addressing the neurological factors that may be contributing to the underlying conditions
However, like any medication, GLP-1 medications can sometimes cause side effects that may impact individuals' experiences with treatment
Data are available to request 6 months after the indication studied has been approved in the US and EU and after primary publication acceptance, whichever is later
At the 0.25 mg starting dose, nausea affects roughly 16 to 20% of users, and it is typically mild
Research Evidence Comparison# MET-097i Research# MET-097i's evidence base includes Phase 1/2 data (7.5% weight loss at Day 36) and Phase 2b VESPER-1 data (up to 14.1% placebo-subtracted weight loss after 28 weekly doses)
)
